As AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the drugs such as Cigna and CVS

from mint - Science https://ift.tt/cSw8Flf
https://ift.tt/74T2zdp

Post a Comment

أحدث أقدم